Revvity | PKI - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Agilent 25.04 2.13 2025-12
Align Technology 22.78 3.05 2026-03
Bio Techne 38.75 81.27 2026-03
Bio-Rad Laboratories 25.28 8.86 2025-12
Bruker 36.79 44.56 2026-03
Celltrion 67.83 17.74 2025-12
Charles River Laboratories 29.26 14.31 2026-03
Cspc Pharmaceutical 24.4 1.13 2025-12
Danaher 29.29 10.39 2026-03
Dentsply International 20.31 9.68 2026-03
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 66.5 5.69 2025-12
Edwards Lifesciences 26.86 4.76 2026-03
Illumina 32.45 2.07 2026-03
Intuitive Surgical 55.82 15.79 2026-03
IQVIA Holdings 19.37 7.21 2026-03
Kangmei Pharma 3.15K 624.19 2025-06
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Laboratory Of America 25.51 4.65 2026-03
Malin Corporation 11.81 0.72 2023-06
Mettler Toledo International 27.34 5.07 2026-03
Neuren Pharmaceuticals 72.14 59.86 2025-12
OraSure Technologies 24.42 12.6 2024-09
Organigram Holdings 235 224.49 2025-09
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 19.13 1.72 2026-03
Qiagen NV 20.54 0.1 2025-12
Quest Diagnostics 22.4 2.63 2026-03
Quidel 2.03 70.39 2025-12
Repligen 109.48 54.58 2026-03
Revvity 30.79 19.08 2026-03
Sartorius 43.44 84.64 2026-03
Sino Biopharmaceutical 17.03 0.89 2025-06
Thermo Fisher Scientific 27.71 3.29 2026-03
Tilray 11.56 80.19 2025-09
Waters 29.75 5.54 2026-03
Zealand Pharma A/S 5.13 0.16 2025-12
Zz Pientze Pharmaceu 47.68 1.35 2026-03